Humanyx

Humanyx is a biotechnology company that pioneered the "Human-on-a-Chip" technology to revolutionize drug discovery and development. Formerly known as Hesperos, the company provides multi-organ, serum-free microphysiological systems that mimic human biology more accurately than traditional animal models. Their platform allows for the simultaneous evaluation of drug efficacy and toxicity across interconnected human tissue modules, such as heart, liver, and neuromuscular junctions. Humanyx's technology has been instrumental in supporting FDA Investigational New Drug (IND) applications, including cases where animal data was insufficient or unavailable. The company operates primarily as a specialized CRO, partnering with pharmaceutical firms to de-risk drug candidates and accelerate the path to clinical trials. Their systems are particularly valuable for studying rare diseases and complex multi-organ interactions that are difficult to replicate in vivo.